Jennifer Wang, M.D., FIDSA

Talk Title: COVID hunters

Jennifer Wang, M.D., FIDSA, is an infectious disease clinician and research scientist who studies the role of innate immune responses to viral infection and how innate immunity contributes to the etiology and pathogenesis of type 1 diabetes. She's made significant contributions to the field of infectious diseases and autoimmunity with more than 70 peer-reviewed publications, including in high-impact scientific journals such as Cell, the New England Journal of Medicine, and Nature Communications. 

For the past decade, Dr. Wang has investigated the evolution of influenza A virus under the selective pressure of antiviral drugs, antibodies, and reassortment. Since early 2020 she has conducted laboratory research on SARS-CoV-2, studying transcriptional findings at the single-cell level in human respiratory samples and utilizing in vitro and in vivo infection models for therapeutic agents.

Dr. Wang is Professor of Medicine with tenure in the Department of Medicine and Diabetes Center of Excellence, University of Massachusetts Chan Medical School. Her research is funded by the National Institutes of Health, DARPA, and the Department of Defense. Since 2020 in response to the COVID-19 pandemic, Dr. Wang is an investigator on numerous clinical trials to treat and prevent SARS-CoV-2 infection.